Article Sidebar

PDF
Date Published: 27/05/2024
Online Published: 27/05/2024
Abstract Views: 5
Views PDF: 6
DOI: https://doi.org/10.58490/ctump.2024i74.2898
Issue
No. 74 (2024)
Section
Article
How to Cite
Nguyen, T. K., Tran , D. H., Nguyen, H. P., Ong, H. T., Vo , N. N. T., Nguyen, P. H. S., Le , T. T. L., & Tran , D. L. (2024). CLARITHROMYCIN RESISTANCE MUTATIONS OF HELICOBACTER PYLORI IN CHILDREN WITH GASTRITIS AND PEPTIC ULCER. Cantho Journal of Medicine and Pharmacy, 74, 187-194. https://doi.org/10.58490/ctump.2024i74.2898

CLARITHROMYCIN RESISTANCE MUTATIONS OF HELICOBACTER PYLORI IN CHILDREN WITH GASTRITIS AND PEPTIC ULCER

Trung Kien Nguyen1,, Do Hung Tran 1, Hong Phong Nguyen1, Huy Thanh Ong2, Nhat Ngan Tuyen Vo 1, Phan Hai Sam Nguyen1, Thi Thuy Loan Le 1, Duc Long Tran 1
1 Can Tho University of Medicine and Pharmacy
2 Can Tho Children’s Hospital

Main Article Content

Abstract

Background: Clarithromycin (CLA) is one of the first-line antibiotics used in the eradication of Helicobacter pylori in children. However, CLA resistance in H. pylori is currently increasing and varies across different regions of the world. This condition is associated with mutations in the macrolide resistance-determining region of the 23S rRNA gene. Objectives: To determine the rate of CLA resistance mutations in the 23S rRNA gene of H. pylori in children aged 6-16 with gastritis, peptic ulcer disease, and some related factors. Materials and methods: A cross-sectional descriptive study was conducted on 59 pediatric patients aged 6-16 with gastritis, peptic ulcer disease, and H. pylori infection at Can Tho Children's Hospital, using gene sequencing to identify CLA resistance mutations. Results: Among H. pylori-infected pediatric patients, the rate of CLA resistance mutations in the 23S rRNA gene was 100%. Eight point mutations were detected in the 23S rRNA gene segment, with nucleotide A being replaced by G at positions 2142 and 2143, and no strain carrying the A2142C mutation. The A2143G and T2182C mutations were the most common, accounting for 91.5% and 96.6%, respectively. There was no statistically significant association between CLA resistance gene mutations and age, gender, endoscopic findings, or history of H. pylori treatment. Conclusion: The rate of CLA resistance in H. pylori among patients with gastritis and peptic ulcer disease in the Mekong Delta region is quite high, warning of the risk of treatment failure with H. pylori eradication regimens containing CLA. Therefore, testing for this antibiotic resistance should be indicated before treatment, especially in cases with a history of treatment failure.

Article Details

Keywords

H.pylori, clarithromycin, antibiotic resistance, 23s-rARN

References

1. Nayoung Kim. Helicobacter pylori, Springer, Singapore. 2016. 3-23. doi 10.1007/978-981287-706-2.
2. Tran DL, Nguyen TK, Nguyen TTC, Le TTL, Tran CL, Le TG, Pham DT, Nguyen MP. Prevalence and eradication efficacy of Helicobacter pylori infection in children in the Mekong delta, Vietnam: a cross-sectional study. Pharmacia. 2022. 69(2): 535–541. https://doi.org/10.3897/pharmacia.69.e85554.
3. Jones L.N., Koletzko S., Goodman K., et al. Joint ESPGHAN/NASPGHAN guidelines for the management of Helicoabcter pylori in children and adolescents. Journal Peadiatric Gastroenterology nutrition. 2017. 64 (6), 991-1003, doi: 10.1097/MPG.0000000000001594.
4. Van Thieu H, Duc NM, Nghi BTD, et al. Antimicrobial Resistance and the Successful Eradication of Helicobacter pylori-Induced Gastroduodenal Ulcers in Vietnamese Children. Medical archives (Sarajevo, Bosnia and Herzegovina). 2021. 75(2), 112-115, doi: 10.5455/medarh.2021.75.112-115.
5. Nguyễn Hữu Hiếu, Nguyễn Thị Việt Hà. Đặc điểm lâm sàng, cận lâm sàng và tình trạng kháng kháng sinh của trẻ bị loét dạ dày tá tràng có nhiễm Helicobacter pylori. Tạp chí Nghiên cứu Y học. 2021. 143(7).
6. Tăng Lê Châu Ngọc, Nguyễn Anh Tuấn, Nguyễn Minh Ngọc, Nguyễn Trọng Trí, Võ Hoàng Khoa và cộng sự. Đặc điểm đề kháng kháng sinh và đáp ứng điều trị trên trẻ viêm dạ dày do Helicobacter Pylori. Y học Thành phố Hồ Chí minh. 2018. 1-5.
7. Miyata E., Kudo T., Ikuse T. et al. Eradication therapy for Helicobacter pylori infection based on the antimicrobial susceptibility test in children: A single-center study over 12 years. Helicobacter. 2021. 26(1), p.e12764.
8. Nguyễn Thành Nam. Nghiên cứu tình hình phát hiện vi khuẩn Helicobacter pylori trong nước bọt bằng kỹ thuật REAL-TIME PCR trên bệnh nhân viêm, loét dạ dày-tá tràng tại Bệnh viện trường đại học Y Dược Cần Thơ năm 2020-2021. Luận văn thạc sỹ xét nghiệm Y học. Trường Đại học Y Dược Cần Thơ. 2021. 88.
9. Zhang Y, Wen Y, Xiao Q, Zheng W, Long G, Chen B, Shu X, Jiang M. Mutations in the Antibiotic Target Genes Related to Clarithromycin, Metronidazole and Levofloxacin Resistance in Helicobacter pylori Strains from Children in China. Infect Drug Resist. 2020. 30(13):311-322.
10. Nguyễn Thúy Vinh, Đỗ Nguyệt Ánh, Nguyễn Thị Hồng Hạnh. Xác định tính kháng clarithromycin của vi khuẩn Helicobacter pylori bằng phương pháp PCR giải trình tự gen 23S rRNA từ bệnh phẩm sinh thiết. 2015.
11. Tran V. H., Ha T. M. T., Le P. T. Q. et al. Helicobacter pylori 23S rRNA gene mutations associated with clarithromycin resistance in chronic gastritis in Vietnam, J Infect Dev Ctries. 12(7), 526-532.
12. Yamade M., Sugimoto M., Uotani T. et al. Resistance of Helicobacter pylori to quinolones and clarithromycin assessed by genetic testing in Japan. J Gastroenterol Hepatol. 26(9), 1457-61.
13. Zhang Y., Wen Y., Xiao Q. et al. Mutations in the Antibiotic Target Genes Related to Clarithromycin, Metronidazole and Levofloxacin Resistance in Helicobacter pylori Strains from Children in China. Infect Drug Resist. 2020. 13, 311-322.
14. Garcia M., Raymond J., Garnier M. et al. Distribution of spontaneous gyrA mutations in 97 fluoroquinolone-resistant Helicobacter pylori isolates collected in France. Antimicrob Agents Chemother. 2012. 56(1), 550-1.